Opportunity

Simpler Grants.gov #PAR-25-193

NIH Solicitation for Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial Required)

Buyer

National Institutes of Health

Posted

November 27, 2024

Respond By

September 07, 2026

Identifier

PAR-25-193

NAICS

541715, 621420, 622210

The National Institutes of Health (NIH), through the National Institute on Alcohol Abuse and Alcoholism, is seeking applications for research grants focused on alcohol treatment, pharmacotherapy, and recovery, requiring an R34 clinical trial. - Government Buyer: - National Institutes of Health (NIH) - National Institute on Alcohol Abuse and Alcoholism - Products/Services Requested: - Research and clinical trial services targeting alcohol health services - Emphasis on increasing access to treatment, improving treatment appeal, analyzing cost structures and insurance, disseminating evidence-based approaches, and reducing health disparities in alcohol use disorder (AUD) treatment - OEMs and Vendors: - No specific OEMs or vendors are mentioned, as this is a grant for research and services - Unique or Notable Requirements: - R34 clinical trial required - Focus on closing the treatment gap for AUD - Addressing health disparities in treatment for health disparity populations - Eligible applicants include government agencies, nonprofits, businesses, and educational institutions - No cost sharing or matching required - Place of Performance: - National Institutes of Health (federal office) - No specific products, part numbers, or quantities are requested, as this is a research grant opportunity

Description

The National Institute on Alcohol Abuse and Alcoholism is soliciting applications for an R34 Clinical Trial Optional mechanism focusing on alcohol health services. The solicitation aims to close the treatment gap for individuals with alcohol use disorder (AUD) by emphasizing five major areas: increasing access to treatment, making treatment more appealing, examining cost structures and insurance systems, studying dissemination and implementation of evidence-based treatments, and reducing health disparities in AUD treatment. Eligible applicants include various government entities, nonprofits, businesses, educational institutions, and other organizations. The funding instrument is a grant with no cost sharing or matching requirement.

View original listing